Leadership

Dr. ShuldinerAlan R. Shuldiner, MD
Professor of Medicine
Head, Division of Endocrinology, Diabetes & Nutrition
Director, Human Genetics Program, University of Maryland School of Medicine
K12 Principal Investigator & Program Director

Dr. Shuldiner  studies the genetics of complex disorders including type 2 diabetes, insulin resistance and obesity. Identification of susceptibility genes for these disorders will provide novel avenues for therapy and prevention. Utilizing candidate gene and positional cloning approaches, he searches for susceptibility genes for diabetes and obesity, as well as gene variants that may predict responsivity to medications used to treat diabetes (pharmacogenomics). These studies have led to the identification of genetic variants in the beta-3-adrenergic receptor and peroxisome proliferator activated receptor-gamma (PPAR-gamma), which are susceptibility genes for obesity and/or type 2 diabetes. Collaborations with investigators throughout the world provide access to thousands of DNA samples from diverse populations for these studies including Pima Indians, Mexican Americans and African Americans. In addition, in his Amish Research Clinic in Strasburg, PA, Dr. Shuldiner has recruited and studied over 2,500 Old Order Amish subjects for a genome-wide scan and positional cloning of susceptibility genes for complex diseases including type 2 diabetes, obesity, osteoporosis, hypertension and longevity, as well as to dissect gene-environment interactions in shaping the risk of cardiovascular disease.


Dr. TacketCarol O. Tacket, MD
Professor of Medicine
Chief, Adult Clinical Studies Section, Center for Vaccine Development
Program Director, University of Maryland General Clinical Research Center
K12 Co-Program Director

 Dr. Tacket conducts Phase 1 and 2 clinical trials of experimental vaccines, primarily those directed against enteric infections such as cholera, typhoid and E. coli, and of other biologics, such as mucosal adjuvants, transgenic plant-based vaccines and milk immunoglobulin concentrates.  Dr. Tacket is interested in novel approaches to mucosal vaccination, including live viral and bacterial vectors, attenuated strains, plant-based vaccines, and mucosal adjuvants.  She develops Phase 1 and 2 clinical protocols in which volunteers from the community enroll, and supervises clinical nursing staffs involved in inpatient and outpatient vaccination studies and oversees regulatory affairs.  She is involved with inpatient challenge studies, when appropriate, to test efficacy of candidate vaccines.  Dr. Tacket is the Program Director of the School of Medicine's General Clinical Research Center (GCRC).  


Dr. RoghmannMary-Claire Roghmann, M.D., M.S.,
Associate Professor
Head, Division of Healthcare Outcomes Research,  Department of Epidemiology & Preventive Medicine

Dr. Roghmann is the principal investigator of the University of Maryland’s Clinical Research Curriculum Award (K30). She is responsible for advising K12 Scholars on their didactic training. 

Dr. Roghmann is an infection disease physician whose research interests are focused on understanding the determinants and the outcomes of infections caused by antibiotic resistant bacteria particularly methicillin-resistant S. aureus. She has specific methodologic expertise in epidemiology and outcomes research, which she gained through a Masters degree. However, like many clinical investigators, she works with a multidisciplinary research team of biostatisticians, microbiologists, geneticist and others

Multidisciplinary Advisory Committee (MAC)

Per the NIH guidelines, the MAC is responsible for recruiting and selecting CR Scholars to the Program; establishing and reviewing the core curriculum; approving the education and career development plans (e.g., curriculum, mentors, research experience) and customizing an individual career development program for each CR Scholar; providing interim monitoring and evaluation of each CR Scholar’s progress with recommendations for modifications in the plan, if necessary, or termination of a CR Scholar who is not making adequate progress; and monitoring and evaluating the overall effectiveness of the Program.

The current membership of the University of Maryland Baltimore Multidisciplinary Advisory Committee (MAC) is as follows:

  • William T. Carpenter, Jr., M.D., Psychiatry, School of Medicine
  • Michael Donnenberg, M.D., Infectious Diseases, School of Medicine
  • Claire M. Fraser-Liggett, Ph.D.,  Director, The Institute for Genome Sciences
  • Charles D. Howell, M.D., Gastroenterology & Hepatitis, School of Medicine
  • Bruce E. Jarrell, M.D., Vice Dean for Academic Affairs, School of Medicine
  • Steven J. Kittner, M.D., Neurology, School of Medicine
  • Stephen B. Liggett, M.D., Medicine and Physiology, School of Medicine
  • Timothy F. Meiller, D.D.S., Ph.D., Diagnostic Sciences, Dental School
  • James P. Nataro, M.D., Ph.D., Infectious Diseases and Tropical Pediatrics, School of Medicine
  • Ligia Peralta, M.D., Adolescent and Young Adult Medicine, School of Medicine
  • Robert R. Redfield, M.D., Infectious Diseases, Institute for Human Virology
  • Mary-Claire Roghmann, M.D., M.S., Epidemiology & Preventive Medicine, School of Medicine
  • Alan R. Shuldiner, M.D., Endocrinology & Genomics, School of Medicine
  • J. Marc Simard, M.D., Ph.D., Neurosurgery, School of Medicine
  • Barbara A. Smith, Ph.D., RN, Associate Dean for Research, School of Nursing
  • Soren Snitker, M.D., Ph.D., Endocrinology, School of Medicine
  • Carol O. Tacket, M.D., Center for Vaccine Development & General Clinical Research Center, School of Medicine
  • Angela Wilks, PhD., Associate Professor, Pharmaceutical Sciences, School of Pharmacy


 

This site will work and look much better in a modern web browser, such as Internet Explorer 6, Firefox, or Safari 1.2 (Mac)
Copyright © University of Maryland School of Medicine